Insulet (PODD) Gross Margin Growth (3y) (2013 - 2026)
Insulet (PODD) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 264.00 |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 21.00 |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 8.00 |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn | -316.00 |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | 73.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 90.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -3,577.00 |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 113.00 |
| 10 | Insulet | 10.26 Bn | 9.73 Bn | 562.60 Mn | 337.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 337.00 |
| Mar 31, 2026 | 230.00 |
| Dec 31, 2025 | 1,377.00 |
| Sep 30, 2025 | 1,697.00 |
| Jun 30, 2025 | 611.00 |
| Mar 31, 2025 | 89.00 |
| Dec 31, 2024 | 283.00 |
| Sep 30, 2024 | -275.00 |
| Jun 30, 2024 | -256.00 |
| Mar 31, 2024 | 307.00 |
| Dec 31, 2023 | 539.00 |
| Sep 30, 2023 | 291.00 |
| Jun 30, 2023 | 384.00 |
| Mar 31, 2023 | 307.00 |
| Dec 31, 2022 | -526.00 |
| Sep 30, 2022 | -883.00 |
| Jun 30, 2022 | -217.00 |
| Mar 31, 2022 | 413.00 |
| Dec 31, 2021 | 240.00 |
| Sep 30, 2021 | 457.00 |